Prevención cardiovascular en el siglo XXI
  Dr. Rubén Elías Feldman, Dr. Omar Scapin, Dra. Laura Bochatay, Dr. Alberto Brondino, Dr. Daniel Flichtentrei.
librovirtual.swf
 


Bibliografía


Capitulo 1

Capitulo 2

Capitulo 3

Capitulo 4

Capitulo 5

Capitulo 6

Capitulo 7

Capitulo 8

Capitulo 8: Diez formas de fracasar en prevención cardiovascular.

  • Widespread Coronary Inflammation in Unstable Angina. Antonino Buffon, M.D., Luigi M. Biasucci, M.D., M.D., Filippo Crea, M.D., and Attilio Maseri, M.D. NEJM 04.07.2002.
  • CARDIOVASCULAR RISK FACTORS FEBRERO 2005. 34 Factores de riesgo y epidemiología cardiovascular en la mujer S. GÓMEZ-MORENO, G. BARÓN-ESQUIVIAS, E. LAGE,A. MARTÍNEZ
  • Phillips, L. S., Branch, W. T., Cook, C. B.,, et. Al.. (2001). Clinical Inertia. Annals of Internal Medicine, 135, 825-834.
  • Ethan Halm, MD, MPH; Toni Sturm, MD; Pablo Mora, PhD; Jason Wang, PhD; Howard Leventhal, PhD
  • Horne (1997) Representation of medication and treatment. In K. Petrie & J. Weinman (Eds.) Perceptions of health and illness. London: Harwood
  • Horne, R. (2003). Treatment perceptions and self-regulation. In L. D. Cameron, & H. Leventhal (Ed.), The Self-Regulation of Health and Illness Behaviour(pp.138-154).
  • London: Routledge Taylor & Francis Group.
  • Horne, R., & Weinman, J. (1999). Patients’ beliefs about prescribed medicines and their role in adhernce to treatment in chronic physical illness. J. Psychosomatic Res,47, 555-567.Horne, R., & Weinman, J. (2002). Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment in chronic physical i llness. Journal of Psychiatric Research, 47, 555-567. (Data analyzed with AMOS)
  • Ann Behav Med. 1997 Summer;19(3):239-63. Compliance with cardiovascular disease prevention strategies: a review of the research. Burke LE, Dunbar-Jacob JM, Hill MN.
  • Howard Leventhal, Michael Diefenbach, Elaine A. Leventhal, Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions, Cognitive Therapy and Research, Volume 16, Issue 2, Apr 1992, Pages 143 – 163
  • Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy Authors: Larsen J.; V accheri A.; Andersen M.; Montanaro N.; Bergman U.Source: British Journal of Clinical Pharmacology, Volume 49, Number 5, May 2000, pp. 463-471(9) Publisher:Blackwell Publishing
  • AHA Statistical Update. Circulation. 2006;113:e85-e151.). © 2006 American Heart Association, Inc. Heart Disease and Stroke Statistics—2006 Update.A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
  • Mosca L, Mochari H, Christian A, Berra K, Taubert K, Mills T, Burdick KA, Simpson SL. Related Articles, Links
  • National study of women’s awareness, preventive action, and barriers to cardiovascular health.Circulation. 2006 Jan 31;113(4):525-34.
  • Maglio Francisco; Reflexiones y algunas confesiones. Publicaciones Latinoamericanas 2.004
  • Geertz Clifford; The Interpretation of Cultures, Basic Books, Nueva York, 1973;
  • Aguirre Patricia; “Qué comen los argentinos que comen” Colección Políticas Públicas, Ciepp, Miño y Dávila Editores
  • EUROACTION: a nurse lead multidisciplinary preventive cardiology programme for coronary patients, high risk individuals and their families. Core syllabus topic : Cardiovascular Disease Prevention - Risk Assessment and Management. Wolrd Congress of Cardiology, Barcelona, Spain 2006.
    http://www.escardio.org/knowledge/congresses/CongressReports/ hotlinesandctus/707003_Wood.htm
  • Antonino Buffon, M.D., Luigi M. Biasucci, M.D., M.D., Filippo Crea, M.D., and Attilio Maseri, M.D. NEJM 04.07.2002.Widespread Coronary Inflammation in Unstable Angina.
  • John F. Keaney, Jr., M.D. Joseph A. Vita, M.D. NEJM:04.07.2002.The Value of Inflammation for Predicting Unstable Angina.
  • Russell Ross, Ph.D. NEJM 14.01.99. Atherosclerosis An Inflammatory Disease.
  • Roberto Corti, MD; Valentin Fuster, MD, Juan J. Badimon. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging (Circulation Nov. 18 de 2.002).
  • Winter et al, PCR and PTCA. European Heart Journal Vol: 23, N° 12, June 2.002
  • Luciardi,Muntaner, Altman. Aterogénesis y Aterotrombosis. FAC, Vol: 31.N° 4, 2.002.
  • Dominick J. Angiolillo, Luiggi M. Biascucci, Giovanna Iluso, Filippo Crea. La i nflamación en los síndromes coronarios agudos. Revista española de cardiología, 2.004; 57 (5): 443-46
  • Goran K. Hansson, M.D, Ph. D. Inflammation, Atherosclerosis and coronary artery disease.
  • New England Jounral of Medicine, 352: 16 pag: 1.685/1.695; April 21, 2.005
  • Canguilheim George: “escritos sobre medicina”, Amorrortu ediciones, Bs As 2004.